Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI
|ClinicalTrials.gov Identifier: NCT00406536|
Recruitment Status : Completed
First Posted : December 4, 2006
Last Update Posted : January 14, 2013
Avanti Polar Lipids, Inc.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by (Responsible Party):
Walter A. Shaw, Ph.D, Avanti Polar Lipids, Inc.
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Primary Completion Date :||June 2012|
|Study Completion Date :||June 2012|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Stallings VA, Schall JI, Maqbool A, Mascarenhas MR, Alshaikh BN, Dougherty KA, Hommel K, Ryan J, Elci OU, Shaw WA. Effect of Oral Lipid Matrix Supplement on Fat Absorption in Cystic Fibrosis: A Randomized Placebo-Controlled Trial. J Pediatr Gastroenterol Nutr. 2016 Dec;63(6):676-680.
Schall JI, Mascarenhas MR, Maqbool A, Dougherty KA, Elci O, Wang DJ, Altes TA, Hommel KA, Shaw W, Moore J, Stallings VA. Choline Supplementation With a Structured Lipid in Children With Cystic Fibrosis: A Randomized Placebo-Controlled Trial. J Pediatr Gastroenterol Nutr. 2016 Apr;62(4):618-26. doi: 10.1097/MPG.0000000000001004.
Groleau V, Schall JI, Dougherty KA, Latham NE, Maqbool A, Mascarenhas MR, Stallings VA. Effect of a dietary intervention on growth and energy expenditure in children with cystic fibrosis. J Cyst Fibros. 2014 Sep;13(5):572-8. doi: 10.1016/j.jcf.2014.01.009. Epub 2014 Feb 8.